This is a nice feel good article from The Green Fund. Note that the Epiduo data they refer to when comparing 1503’s performance after 12 weeks is the 4 week data of Epiduo that is spruiked by BOT. But it does make a nice case on the safety side of things.
http://www.botanixpharma.com/wp-content/uploads/Botanix-Pharma-BTX1503-Phase-II-Top-Line-Data-1-002.pdf
Objective Views on Lead product: BTX 1503 (Acne), page-48
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.8¢ |
Change
-0.003(0.78%) |
Mkt cap ! $577.0M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 32.5¢ | 31.8¢ | $753.4K | 2.350M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 769414 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 87842 | 4 |
View Market Depth
| Last trade - 11.34am 15/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |